ACOG
Price
$5.06
Change
+$0.14 (+2.85%)
Updated
Apr 24 closing price
Capitalization
81.06M
IPHA
Price
$2.01
Change
+$0.01 (+0.50%)
Updated
Apr 24 closing price
Capitalization
171.62M
18 days until earnings call
Ad is loading...

ACOG vs IPHA

Header iconACOG vs IPHA Comparison
Open Charts ACOG vs IPHABanner chart's image
Alpha Cognition
Price$5.06
Change+$0.14 (+2.85%)
Volume$24.69K
Capitalization81.06M
Innate Pharma SA
Price$2.01
Change+$0.01 (+0.50%)
Volume$7.49K
Capitalization171.62M
ACOG vs IPHA Comparison Chart
Loading...
ACOG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IPHA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACOG vs. IPHA commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACOG is a StrongBuy and IPHA is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 25, 2025
Stock price -- (ACOG: $5.06 vs. IPHA: $2.01)
Brand notoriety: ACOG and IPHA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACOG: 39% vs. IPHA: 3%
Market capitalization -- ACOG: $81.06M vs. IPHA: $171.62M
ACOG [@Biotechnology] is valued at $81.06M. IPHA’s [@Biotechnology] market capitalization is $171.62M. The market cap for tickers in the [@Biotechnology] industry ranges from $275.91B to $0. The average market capitalization across the [@Biotechnology] industry is $2.16B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACOG’s FA Score shows that 1 FA rating(s) are green whileIPHA’s FA Score has 1 green FA rating(s).

  • ACOG’s FA Score: 1 green, 4 red.
  • IPHA’s FA Score: 1 green, 4 red.
According to our system of comparison, IPHA is a better buy in the long-term than ACOG.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACOG’s TA Score shows that 6 TA indicator(s) are bullish while IPHA’s TA Score has 6 bullish TA indicator(s).

  • ACOG’s TA Score: 6 bullish, 2 bearish.
  • IPHA’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, ACOG is a better buy in the short-term than IPHA.

Price Growth

ACOG (@Biotechnology) experienced а +22.82% price change this week, while IPHA (@Biotechnology) price change was +2.03% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.06%. For the same industry, the average monthly price growth was -5.30%, and the average quarterly price growth was -11.62%.

Reported Earning Dates

ACOG is expected to report earnings on Mar 31, 2025.

IPHA is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Biotechnology (+8.06% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IPHA($172M) has a higher market cap than ACOG($81.1M). IPHA YTD gains are higher at: 9.239 vs. ACOG (-14.092).
ACOGIPHAACOG / IPHA
Capitalization81.1M172M47%
EBITDA-14.46MN/A-
Gain YTD-14.0929.239-153%
P/E RatioN/AN/A-
Revenue0N/A-
Total Cash3.67MN/A-
Total Debt2.21MN/A-
TECHNICAL ANALYSIS
Technical Analysis
ACOGIPHA
RSI
ODDS (%)
Bullish Trend 1 day ago
88%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
83%
Momentum
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
72%
MACD
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
68%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
75%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
73%
Advances
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
72%
Declines
ODDS (%)
Bearish Trend 9 days ago
87%
Bearish Trend 19 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
87%
Aroon
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
89%
View a ticker or compare two or three
Ad is loading...
ACOG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IPHA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SLVYX22.91N/A
N/A
Saratoga Large Capitalization Value A
TVLYX11.09N/A
N/A
Touchstone Value Y
DLACX13.32N/A
N/A
BNY Mellon Large Cap Equity Y
JHUKX30.85N/A
N/A
JPMorgan Emerging Markets Equity R4
PGHAX62.28N/A
N/A
Putnam Global Health Care R6

ACOG and

Correlation & Price change

A.I.dvisor tells us that ACOG and VRCA have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ACOG and VRCA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACOG
1D Price
Change %
ACOG100%
+2.85%
VRCA - ACOG
31%
Poorly correlated
+1.70%
COGT - ACOG
27%
Poorly correlated
+0.89%
BLTE - ACOG
26%
Poorly correlated
+1.34%
IPHA - ACOG
24%
Poorly correlated
+0.73%
CDIO - ACOG
21%
Poorly correlated
+13.69%
More

IPHA and

Correlation & Price change

A.I.dvisor indicates that over the last year, IPHA has been loosely correlated with MDGL. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if IPHA jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IPHA
1D Price
Change %
IPHA100%
+0.73%
MDGL - IPHA
43%
Loosely correlated
+3.61%
SLNO - IPHA
34%
Loosely correlated
+2.71%
VALN - IPHA
30%
Poorly correlated
+0.08%
QSI - IPHA
28%
Poorly correlated
+4.27%
VKTX - IPHA
27%
Poorly correlated
-0.50%
More